Released on: February 28, 2008, 4:30 am

Press Release Author: Prasanth/Mediacom PR

Industry: Healthcare

Press Release Summary: Obesity Surgery can lead to weight loss and diabetes reversal

Press Release Body:



Bangalore: Gastric bypass surgery is the cure for a variety of people who have type
2 diabetes. For type 2 diabetes the best medicine is weight loss. Obesity is making
the headlines in every obesity from overweight to morbid obesity. Both women and men
are about equally represented. The world is round and so are a growing number of its
inhabitants. Consider these staggering statistics. With more than 1.2 billion people
in the world now officially classified as overweight, according to the World Health
Organization (WHO), this is probably the most sedentary generation of people in the
history of the world. India alone accounts for more than 25 million people suffering
from morbid obesity.



Dr. Rajsekhar Nayak, leading Bariatric surgeon, MBBS, MS, FRCS Edinburgh UK and FRCS
Glasgow UK, Director, Nayak Institute of Gastroenterology, a division of Gunasheela
Hospital, Bangalore said "But many obese people just can't shed pounds with diet and
exercise alone. The latest research shows that weight loss surgery not only helps
patients to lose weight, but in many cases cures their diabetes as well. The most
commonly performed bariatric surgery is known as gastric bypass surgery, where the
stomach size is reduced and the small intestine re-routed to minimize calorie
intake. It appears that gastric bypass surgery is the cure for a variety of people
who have Type 2 diabetes. It seems that the re-routing of the food alters the way
hormones are secreted from the foregut and from the pancreas and that seems to have
an effect on type 2 diabetes that occurs even before people lose weight." For
further details and appointments, please contact on 080 - 6535 1256/ 98450 45758.



\"People who have type 2 diabetes who are seriously overweight are good candidates
for a gastric bypass,\" Dr. Rajsekhar Nayak observes. \"Gastric bypass will have
dramatic effects on their diabetes. And the sooner they have it, the better the
results will be. \"



Dr. Rajsekhar Nayak points out that people can only qualify for bariatric surgery if
they meet certain criteria for obesity and related health conditions: \"This is major
surgery, no doubt, and that comes with a variety of risks including, in a small
percentage of cases, even death."







Diabetes is emerging as a global public health problem. India tops the list in the
prevalence of diabetes in the whole world with a burden of 35.5 million people with
diabetes. The prevalence staggers around 12-15% in the urban areas and 6-8% in the
rural areas. One third of persons with diabetes in the urban areas and 50% of the
people in the rural areas are yet to be detected because of the asymptomatic nature
of the disorder. In general, people do not go for diabetes test consciously and they
are detected whenever they go for treatment for other illness. Diabetes mellitus
type 2 affects more than 150 million people worldwide. Although the incidence of
complications of type 2 diabetes can be reduced with tight control of hyperglycemia,
current therapies do not achieve a cure. Some operations for morbid obesity not only
induce significant and lasting weight loss but also lead to improvements in or
resolution of comorbid disease states, especially type 2 diabetes.


Gastric bypass and biliopancreatic diversion seem to achieve control of diabetes as
a primary and independent effect, not secondary to the treatment of overweight.
Although controlled trials are needed to verify the effectiveness on non-obese
individuals, gastric bypass surgery has the potential to change the current concepts
of the pathophysiology of Type 2 diabetes and, possibly, the management of this
disease. Patients with type 2 diabetes have a six fold increased risk of a
first-time myocardial infarction compared with non-diabetic patients. Additionally,
diabetic patients have twice the risk of myocardial infarction. As cardiovascular
mortality is the leading single cause of death in India. and because patients with
type 2 diabetes have a three- to eightfold increased risk of death, new treatment
strategies need to be considered for this disease and its prevention.



Dr. Rajsekhar Nayak discussed a study conducted in US on 87 patients who were
operated to review the effect of morbid obesity surgery on type 2 diabetes mellitus,
and to analyze data that might explain the mechanisms of action of these surgeries
and that could answer the question of whether surgery for morbid obesity can
represent a cure for type 2 diabetes in non obese patients as well. World over it
has been proved that after gastric bypass and biliopancreatic diversion achieve
durable normal levels of plasma glucose, plasma insulin, and glycosylated hemoglobin
in 80% to 100% of severely obese diabetic patients, usually within days after
surgery. Available data show a significant change in the pattern of secretion of
gastrointestinal hormones. Case reports have also documented remission of type 2
diabetes in non-morbidly obese individuals undergoing biliopancreatic diversion for
other indications.



Dr. Rajsekhar Nayak describes the effects of laparoscopic gastric bypass surgery on
the development of type 2 diabetes. All patients had severe obesity (BMI 35.0
kg/m2). One year after surgery, 64% patients had remission of diabetes. The
prevalence of diabetes decreased from 10 to 5.6%. An additional 26% of patients with
diabetes had an improvement in their control of diabetes.



While gastric bypass surgery may be hopeful for the severely obese, it must be
tested prospectively in obese individuals before it can be recommended as a
treatment for Type 2 diabetes. More importantly, new strategies are needed to
prevent the progression of impaired fasting glucose and impaired glucose tolerance
to Type 2 diabetes. Laparoscopic gastric bypass surgery may be the first to offer
promise.



Web Site: http://www.gulfu.in

Contact Details: Prasanth Chandran